Literature DB >> 1671711

Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.

W Debinski1, C B Siegall, D Fitzgerald, I Pastan.   

Abstract

TGF alpha-PE40 is a chimeric toxin made by replacing domain Ia of Pseudomonas exotoxin (PE) with transforming growth factor alpha (TGF alpha). We have now replaced a portion of domain Ib of PE with different polypeptides or an extra domain III of PE in transforming growth factor alpha-PE40 and maintained cell killing. Thus, TGF alpha-PE40 can be used to transport foreign protein sequences into the cytosol of cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671711      PMCID: PMC369490          DOI: 10.1128/mcb.11.3.1751-1753.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   5.069


  16 in total

1.  Structure and activity of diphtheria toxin. I. Thiol-dependent dissociation of a fraction of toxin into enzymically active and inactive fragments.

Authors:  R J Collier; J Kandel
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

2.  Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.

Authors:  V K Chaudhary; T Mizukami; T R Fuerst; D J FitzGerald; B Moss; I Pastan; E A Berger
Journal:  Nature       Date:  1988-09-22       Impact factor: 49.962

3.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

4.  Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.

Authors:  H Lorberboum-Galski; D FitzGerald; V Chaudhary; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin.

Authors:  C B Siegall; Y H Xu; V K Chaudhary; S Adhya; D Fitzgerald; I Pastan
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.834

6.  Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol.

Authors:  M Ogata; V K Chaudhary; I Pastan; D J FitzGerald
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.486

7.  Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

Authors:  V S Allured; R J Collier; S F Carroll; D B McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 12.779

8.  Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin.

Authors:  V K Chaudhary; D J FitzGerald; S Adhya; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 12.779

9.  Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity.

Authors:  C M Douglas; R J Collier
Journal:  J Bacteriol       Date:  1987-11       Impact factor: 3.476

10.  Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.

Authors:  C B Siegall; V K Chaudhary; D J FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 12.779

View more
  4 in total

1.  Infectious enveloped RNA virus antigenic chimeras.

Authors:  S D London; A L Schmaljohn; J M Dalrymple; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.

Authors:  Hetal Pandya; Waldemar Debinski
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

3.  Molecular targeting of intracellular compartments specifically in cancer cells.

Authors:  Hetal Pandya; Denise M Gibo; Waldemar Debinski
Journal:  Genes Cancer       Date:  2010-05

4.  A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity.

Authors:  John E Weldon; Laiman Xiang; Oleg Chertov; Inger Margulies; Robert J Kreitman; David J FitzGerald; Ira Pastan
Journal:  Blood       Date:  2008-11-06       Impact factor: 25.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.